Search
GeoVax Labs Inc
GOVXAdd to Watchlist
0.741USD
+0.023+3.15%
Market hours （ET）Quotes delayed by 15 min
5.46MMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-08-14The current earnings forecast score of GeoVax Labs Inc is 8.00, ranking 170 out of 387 in the Biotechnology & Medical Research industry. The average price target is 8.50, with a high of 14.00 and a low of 6.00.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
73.333
Target Price
+10113.56%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
497
Total
6
Median
7
Average
Company name
Ratings
Analysts
GeoVax Labs Inc
GOVX
2
Beigene Ltd
ONC
28
argenx SE
ARGX
28
Ionis Pharmaceuticals Inc
IONS
25
IQVIA Holdings Inc
IQV
24
Kymera Therapeutics Inc
KYMR
23
1
2
3
...
100
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is GeoVax Labs Inc's price target?
Analysts forecast that GeoVax Labs Inc's price target is USD 8.50, with the highest forecast at USD 14.00 and the lowest forecast at USD 6.00.
How have GeoVax Labs IncGOVX's recent earnings per share performed?
The market expectation was USD -0.97, while GeoVax Labs IncGOVX's earnings per share (EPS) for the previous quarter was USD -2.62. EPS for the next quarter is expected at USD -3.28.
What is the analyst rating for GeoVax Labs Inc?
Based on the ratings of GeoVax Labs Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.